Actemra 162 MG/0.9 ML syringe 0.9ML
Ended Awarded
- Contract number
- SPE2DB25FNWVN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,505
Award facts
- Contract value 100% obligated
- $3,504.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $3,504.62 to AmerisourceBergen Drug Corp for ACTEMRA (tocilizumab) 162 mg/0.9 mL syringes on September 24, 2025, with an ultimate completion date of September 25, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. ACTEMRA is a biologic immunosuppressant medication used primarily to treat rheumatoid arthritis and other inflammatory conditions, representing a specialized pharmaceutical supply critical to federal medical programs.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving entities including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor and critical vendor in the federal medical supply chain, AmerisourceBergen Drug Corp maintains an extensive portfolio of contract awards demonstrating its capability to fulfill complex federal procurement requirements for specialty medications and healthcare commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FNWVN?
SPE2DB25FNWVN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FNWVN worth?
The government has obligated $3,505 on SPE2DB25FNWVN.
Is contract SPE2DB25FNWVN an order under another contract?
Yes. SPE2DB25FNWVN is a delivery order under SPE2DB25D3201, an indefinite delivery contract.
Was contract SPE2DB25FNWVN competed?
The extent of competition for SPE2DB25FNWVN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award